Xenetic Biosciences, Inc.
XBIO
$3.99
$0.112.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.58M | 2.50M | 2.52M | 2.52M | 2.45M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.58M | 2.50M | 2.52M | 2.52M | 2.45M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 2.58M | 2.50M | 2.52M | 2.52M | 2.45M |
| SG&A Expenses | 3.24M | 3.42M | 3.66M | 3.65M | 3.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.46M | 6.70M | 6.88M | 7.53M | 7.31M |
| Operating Income | -3.88M | -4.20M | -4.36M | -5.01M | -4.87M |
| Income Before Tax | -3.67M | -3.96M | -4.08M | -4.70M | -4.47M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.67 | -3.96 | -4.08 | -4.70 | -4.47 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.67M | -3.96M | -4.08M | -4.70M | -4.47M |
| EBIT | -3.88M | -4.20M | -4.36M | -5.01M | -4.87M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -2.38 | -2.57 | -2.65 | -3.05 | -2.92 |
| Normalized Basic EPS | -1.49 | -1.61 | -1.65 | -1.91 | -1.82 |
| EPS Diluted | -2.38 | -2.57 | -2.65 | -3.06 | -2.92 |
| Normalized Diluted EPS | -1.49 | -1.61 | -1.65 | -1.91 | -1.82 |
| Average Basic Shares Outstanding | 6.17M | 6.17M | 6.16M | 6.15M | 6.14M |
| Average Diluted Shares Outstanding | 6.17M | 6.17M | 6.16M | 6.15M | 6.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |